Skip to Content
You are currently on the new version of our website. Access the old version .

Current Oncology, Volume 29, Issue 4

2022 April - 59 articles

Cover Story: Visceral artery erosion remains a rare, yet lethal complication after oncologic surgery of the upper GI tract or pancreatitis. A cohort of 65 patients with visceral artery erosion bleeding was analyzed retrospectively in order to compare results of endovascular and open surgical treatment options. A total of 57 % of the patients underwent endovascular treatment (EVT) and 43% had open surgery (OS) as a primary treatment. Postoperative morbidity and complications were higher in the OS group than in the EVT group (41% vs. 68%, p = 0.029). The in-hospital 30-day mortality rate for all patients was 25%, with higher rates in the OS group than in the EVT group (14% vs. 39%, p = 0.017). EVT may be beneficial for suitable patients with visceral artery erosion to reduce surgical complications, and it may be associated with better in-hospital survival. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (59)

  • Review
  • Open Access
43 Citations
12,071 Views
16 Pages

18 April 2022

Immune checkpoint inhibitors (ICIs) have emerged as novel options that are effective in treating various cancers. They are monoclonal antibodies that target cytotoxic T-lymphocyte antigen 4 (CTLA-4), programmed cell death 1 (PD-1), and programmed cel...

  • Article
  • Open Access
7 Citations
3,592 Views
7 Pages

Robot-Assisted Radical Prostatectomy for Potential Cancer Control in Patients with Metastatic Prostate Cancer

  • Kimiaki Takagi,
  • Makoto Kawase,
  • Daiki Kato,
  • Kota Kawase,
  • Manabu Takai,
  • Koji Iinuma,
  • Keita Nakane,
  • Noriyasu Hagiwara,
  • Toru Yamada and
  • Takuya Koie
  • + 1 author

18 April 2022

Recently, cytoreductive prostatectomy for metastatic prostate cancer (mPCa) has been associated with improved oncological outcomes. This study was aimed at evaluating whether robot-assisted radical prostatectomy (RARP) as a form of cytoreductive pros...

  • Article
  • Open Access
1 Citations
3,552 Views
16 Pages

Motivation to Consent and Adhere to the FORT Randomized Controlled Trial

  • Christine Maheu,
  • Valerie Lok,
  • Jacqueline Galica,
  • Mali Tse,
  • Emma Maltus,
  • Lauriane Giguère,
  • Wing Lam Tock and
  • Sophie Lebel

17 April 2022

The aim of this qualitative study was to identify the motivational factors that influence cancer survivors to participate and adhere to the fear of cancer recurrence (FCR) FORT randomized controlled trial (RCT). Fifteen women diagnosed with breast an...

  • Review
  • Open Access
9 Citations
4,488 Views
13 Pages

New Targeted Therapies and Combinations of Treatments for Cervical, Endometrial, and Ovarian Cancers: A Year in Review

  • Adelina Silvana Gheorghe,
  • Elena Adriana Dumitrescu,
  • Isabela Anda Komporaly,
  • Raluca Ioana Mihăilă,
  • Cristian Virgil Lungulescu and
  • Dana Lucia Stănculeanu

17 April 2022

This review of the meaningful data from 2021 on cervical, endometrial, and ovarian cancers aims to provide an update of the most clinically relevant studies presented at important oncologic congresses during the year (the American Society of Clinical...

  • Article
  • Open Access
7 Citations
3,869 Views
12 Pages

DTI Abnormalities Related to Glioblastoma: A Prospective Comparative Study with Metastasis and Healthy Subjects

  • Youssef El Ouadih,
  • Bruno Pereira,
  • Julian Biau,
  • Béatrice Claise,
  • Rémi Chaix,
  • Pierre Verrelle,
  • Toufik Khalil,
  • Xavier Durando and
  • Jean-Jacques Lemaire

16 April 2022

(1) Background: Glioblastoma multiforme (GBM) shows complex mechanisms of spreading of the tumor cells, up to remote areas, and little is still known of these mechanisms, thus we focused on MRI abnormalities observable in the tumor and the brain adja...

  • Article
  • Open Access
21 Citations
4,220 Views
15 Pages

16 April 2022

Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-related death. The high mortality and morbidity associated with EOC are mostly due to late diagnosis and chemotherapy drug resistance. Currently, the standard first-line che...

  • Article
  • Open Access
1 Citations
2,673 Views
10 Pages

16 April 2022

The BC-brain questionnaire was developed by BC Cancer to detect health problems in patients with central nervous system (CNS) tumours in routine clinical care, treated with radiotherapy (RT), as part of the Prospective Outcomes and Support Initiative...

  • Case Report
  • Open Access
3 Citations
3,525 Views
6 Pages

15 April 2022

Patients with chronic lymphocytic leukemia (CLL) relapsing on ibrutinib are often treated with the Bcl-2 inhibitor venetoclax. However, the transition from one agent to another poses some clinical challenges due to disease flares sometimes occurring...

  • Article
  • Open Access
3 Citations
3,611 Views
16 Pages

Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations

  • Zoé Neviere,
  • Elodie Coquan,
  • Pierre-Emmanuel Brachet,
  • Emeline Meriaux,
  • Isabelle Bonnet,
  • Sophie Krieger,
  • Laurent Castéra,
  • Dominique Vaur,
  • Flavie Boulouard and
  • Florence Joly
  • + 4 authors

15 April 2022

(1) Background: In literature, approximately 20% of mCRPC present somatic DNA damage repair (DDR) gene mutations, and their relationship with response to standard therapies in mCRPC is not well understood. The objective was to evaluate outcomes of mC...

  • Article
  • Open Access
7 Citations
2,716 Views
8 Pages

The Impact of the Ongoing COVID-19 Epidemic on the Increasing Risk of Adverse Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy

  • Łukasz Nyk,
  • Hubert Kamecki,
  • Bartłomiej Zagożdżon,
  • Andrzej Tokarczyk,
  • Piotr Baranek,
  • Łukasz Mielczarek,
  • Piotr Kryst,
  • Sławomir Poletajew,
  • Roman Sosnowski and
  • Stanisław Szempliński

15 April 2022

We aimed to assess whether the ongoing course of the COVID-19 epidemic has been associated with an increased risk of adverse pathology (AP) findings in prostate cancer (PC) patients treated with radical prostatectomy (RP). We performed a retrospectiv...

  • Review
  • Open Access
6 Citations
4,904 Views
19 Pages

Co-Occurrence of EBV-Positive Mucocutaneous Ulcer (EBV-MCU) and CLL/SLL in the Head and Neck Region

  • Patricia Bott,
  • Ilske Oschlies,
  • Andreas Radeloff and
  • Maureen Loewenthal

15 April 2022

EBV-positive mucocutaneous ulcer (EBV-MCU) was classified as a rare new entity of the lymphoproliferative B-cell diseases by the WHO in 2017 and must be distinguished from head and neck squamous cell carcinoma by early biopsy. The aim of the study is...

  • Article
  • Open Access
42 Citations
12,835 Views
14 Pages

The Economic Burden of Cancer in Canada from a Societal Perspective

  • Roxanne Garaszczuk,
  • Jean H. E. Yong,
  • Zhuolu Sun and
  • Claire de Oliveira

14 April 2022

Cancer patients and their families experience considerable financial hardship; however, the current published literature on the economic burden of cancer at the population level has typically focused on the costs from the health system’s perspe...

  • Review
  • Open Access
14 Citations
8,760 Views
15 Pages

Novel Therapies for the Treatment of HER2-Positive Advanced Breast Cancer: A Canadian Perspective

  • Cristiano Ferrario,
  • Anna Christofides,
  • Anil Abraham Joy,
  • Kara Laing,
  • Karen Gelmon and
  • Christine Brezden-Masley

13 April 2022

The advent of anti-HER2 targeted therapies has dramatically improved the outcome of HER2-positive breast cancer; however, resistance to treatment in the metastatic setting remains a challenge, highlighting the need for novel therapies. The arrival of...

  • Article
  • Open Access
4 Citations
2,660 Views
14 Pages

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours

  • Alessandro Lorusso,
  • Dmitry Bichev,
  • Anica Högner,
  • Prisca Bartels,
  • Alexej Ballhausen,
  • Christoph Treese,
  • Matthias Biebl and
  • Peter Thuss-Patience

12 April 2022

The prognostic meaning of weight loss (WL) during standard treatment for operable oesophagogastric cancer is still unclear. The aim of this study is to analyse the prognostic effect of WL during perioperative chemotherapy (PC) for gastric cancer (GC)...

  • Article
  • Open Access
5 Citations
3,510 Views
11 Pages

Serology-Based Model for Personalized Epithelial Ovarian Cancer Risk Evaluation

  • Tianqing Yan,
  • Xiaolu Ma,
  • Haoyun Hu,
  • Zhiyun Gong,
  • Hui Zheng,
  • Suhong Xie,
  • Lin Guo and
  • Renquan Lu

12 April 2022

This study aimed to establish a prognosis-prediction model based on serological indicators in patients with epithelial ovarian cancer (EOC). Patients initially diagnosed as ovarian cancer and surgically treated in Fudan University Shanghai Cancer Cen...

  • Article
  • Open Access
4 Citations
2,553 Views
14 Pages

12 April 2022

Cancer-related cognitive impairment (CRCI) has been frequently reported in colorectal cancer survivors. Heparan sulfate (HS) was gradually considered to be related to cognitive disorders. The effect and potential mechanism of HS on CRCI in colorectal...

  • Article
  • Open Access
7 Citations
3,814 Views
19 Pages

12 April 2022

As the rates of cancer incidence and survival increase in Canada, more patients are living in the post-treatment survivorship phase of their cancer journey. Identifying cancer survivors’ concerns and unmet needs is important so that health care...

  • Article
  • Open Access
12 Citations
3,689 Views
12 Pages

12 April 2022

Radiation-induced fibrosis (RIF) is a severe side effect related with soft tissues sarcomas (STS) radiotherapy. RIF is a multicellular process initiated primarily by TGF-β1 that is increased in irradiated tissue, whose signaling leads to intrace...

  • Communication
  • Open Access
8 Citations
4,207 Views
6 Pages

11 April 2022

Salvage chemotherapy for patients with unresectable pancreatic cancer (UR-PC) who have been treated with gemcitabine and nab-paclitaxel (GnP), and 5-fluorouracil (5-FU)/l-leucovorin (LV) plus nanoliposomal irinotecan (nal-IRI), has not been fully est...

  • Article
  • Open Access
10 Citations
4,018 Views
14 Pages

The Clinically Actionable Molecular Profile of Early versus Late-Stage Non-Small Cell Lung Cancer, an Individual Age and Sex Propensity-Matched Pair Analysis

  • Anna L. McGuire,
  • Melissa K. McConechy,
  • Barb L. Melosky,
  • John C. English,
  • James J. Choi,
  • Defen Peng,
  • John Yee,
  • Benjamin L. S. Furman,
  • Rosalia Aguirre Hernandez and
  • Stephen Yip
  • + 3 authors

11 April 2022

Background: Despite meticulous surgery for non-small cell lung cancer (NSCLC), relapse is as high as 70% at 5 years. Many institutions do not conduct reflexive molecular testing on early stage specimens, although targeted gene therapy may extend life...

  • Systematic Review
  • Open Access
16 Citations
3,122 Views
14 Pages

Pain Relief after Stereotactic Radiotherapy of Pancreatic Adenocarcinoma: An Updated Systematic Review

  • Milly Buwenge,
  • Alessandra Arcelli,
  • Francesco Cellini,
  • Francesco Deodato,
  • Gabriella Macchia,
  • Savino Cilla,
  • Erika Galietta,
  • Lidia Strigari,
  • Claudio Malizia and
  • Alessio G. Morganti
  • + 1 author

11 April 2022

Severe pain is frequent in patients with locally advanced pancreatic ductal adenocarcinoma (PDCA). Stereotactic body radiotherapy (SBRT) provides high local control rates in these patients. The aim of this review was to systematically analyze the ava...

  • Guidelines
  • Open Access
10 Citations
5,394 Views
17 Pages

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

  • Phillip Blanchette,
  • Duvaraga Sivajohanathan,
  • John Bartlett,
  • Andrea Eisen,
  • Harriet Feilotter,
  • Rossanna Pezo,
  • Gulisa Turashvili and
  • Phillip Williams

9 April 2022

Objective: The purpose of this guideline is to determine the clinical utility of multigene profiling assays in individuals with early-stage invasive breast cancer. Methods: This guideline was developed by Ontario Health (Cancer Care Ontario)’s...

  • Article
  • Open Access
4 Citations
3,519 Views
16 Pages

A Qualitative Needs Analysis of Skin Cancer Care from the Perspectives of Patients, Physicians, and Health Insurance Representatives—A Case Study from Eastern Saxony, Germany

  • Josephine Mathiebe,
  • Lydia Reinhardt,
  • Maike Bergmann,
  • Marina Lindauer,
  • Alina Herrmann,
  • Cristin Strasser,
  • Friedegund Meier and
  • Jochen Schmitt

9 April 2022

Skin cancer is one of the most common cancers worldwide and the number of patients is steadily increasing. In skin cancer care, greater interdisciplinary cooperation is required for prevention, early detection, and new complex systemic therapies. How...

  • Article
  • Open Access
17 Citations
3,320 Views
8 Pages

Assessing the Relationship between Socioeconomic Status, Race, and Psychological Distress in Cancer Survivors: A Population Based Study

  • Ikechukwu Chidobem,
  • Fan Tian,
  • Chisom Mgbodile,
  • Francis Mgbodile,
  • Tahereh Orouji Jokar,
  • Esther Ogbuokiri and
  • Nazia Khan

9 April 2022

Psychological distress is more common in cancer survivors than the general population, and is associated with adverse outcomes. This cross-sectional study aimed to assess the relationship between socioeconomic status (SES), race and psychological dis...

  • Article
  • Open Access
8 Citations
3,455 Views
11 Pages

The Learning Curve and Inter-Observer Variability in Contouring the Hippocampus under the Hippocampal Sparing Guidelines of Radiation Therapy Oncology Group 0933

  • Monika Konopka-Filippow,
  • Ewa Sierko,
  • Dominika Hempel,
  • Rafał Maksim,
  • Natalia Samołyk-Kogaczewska,
  • Tomasz Filipowski,
  • Ewa Rożkowska,
  • Stefan Jelski,
  • Beata Kasprowicz and
  • Kamil Szczecina
  • + 2 authors

8 April 2022

Hippocampal-sparing brain radiotherapy (HS-BRT) in cancer patients results in preservation of neurocognitive function after brain RT which can contribute to patients’ quality of life (QoL). The crucial element in HS-BRT treatment planning is ap...

  • Article
  • Open Access
6 Citations
3,883 Views
14 Pages

Laser Interstitial Thermal Therapy in Grade 2/3 IDH1/2 Mutant Gliomas: A Preliminary Report and Literature Review

  • Gabrielle W. Johnson,
  • Rowland H. Han,
  • Matthew D. Smyth,
  • Eric C. Leuthardt and
  • Albert H. Kim

8 April 2022

Laser interstitial thermal therapy (LITT) has become an increasingly utilized alternative to surgical resection for the treatment of glioma in patients. However, treatment outcomes in isocitrate dehydrogenase 1 and 2 (IDH1/2) mutant glioma, specifica...

  • Perspective
  • Open Access
20 Citations
5,452 Views
11 Pages

8 April 2022

Approximately 20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2), providing an actionable target for many different therapies. In the metastatic setting, prognosis has improved greatly with the use of anti-HER2 drugs su...

  • Article
  • Open Access
3 Citations
3,897 Views
9 Pages

Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity

  • J. Connor Wells,
  • Adam Fundytus,
  • Shubham Sharma,
  • Wilma M. Hopman,
  • Joseph C. Del Paggio,
  • Bishal Gyawali,
  • Deborah Mukherji,
  • Nazik Hammad,
  • C. S. Pramesh and
  • Christopher M. Booth
  • + 2 authors

7 April 2022

Background: In this study, we compared and contrasted design characteristics, results, and publications of randomized controlled trials (RCTs) in gastrointestinal (GI), lung, and breast cancer. Methods: A PUBMED search identified phase III RCTs of an...

  • Article
  • Open Access
4 Citations
3,424 Views
14 Pages

Predicting Early Disease Recurrence of Pancreatic Cancer following Surgery: Determining the Role of NUDT15 as a Prognostic Biomarker

  • Daniel Llwyd Hughes,
  • Frances Willenbrock,
  • Zahir Soonawalla,
  • Somnath Mukherjee and
  • Eric O’Neill

6 April 2022

Surgical resection remains the only curative treatment strategy for Pancreatic Ductal Adenocarcinoma (PDAC). A proportion of patients succumb to early disease recurrence post-operatively despite receiving adjuvant chemotherapy. The ability to identif...

  • Case Report
  • Open Access
4 Citations
6,499 Views
7 Pages

EGFR Targeting TKI-Related Skin Toxicities in a Patient with Darker Skin: A Case Report

  • Arman Zereshkian,
  • Alia Thawer,
  • David M. Hwang and
  • Susanna Cheng

5 April 2022

Epidermal growth factor receptor (EGFR) targeting tyrosine kinase inhibitors (TKIs) can result in significant skin toxicities that may impact patients’ quality of life. While these skin reactions are well documented in patients with lighter ski...

  • Opinion
  • Open Access
2 Citations
3,080 Views
5 Pages

Access Denied? The Unintended Consequences of Pending Drug Pricing Rules

  • Alan Kaplan,
  • David J. Stewart,
  • Gerald Batist,
  • Silvana Spadafora,
  • Sandeep Sehdev and
  • Shaun G. Goodman

2 April 2022

The government of Canada now plans to bring into force new federal drug pricing regulations on 1 July 2022. We do not take issue with the goal of medication affordability, which is vital in healthcare the world over. Our concern is that the new guide...

  • Article
  • Open Access
7 Citations
3,162 Views
14 Pages

Psychological Determinants of Men’s Adherence to Cascade Screening for BRCA1/2

  • Giulia Ongaro,
  • Serena Petrocchi,
  • Mariarosaria Calvello,
  • Bernardo Bonanni,
  • Irene Feroce and
  • Gabriella Pravettoni

2 April 2022

BRCA1/2 germline mutations predispose carriers to an increased risk of breast, ovarian, prostate, pancreatic, and skin cancer. Men and women are equally likely to pass on or inherit the pathogenic variant. However, there is evidence that male relativ...

  • Commentary
  • Open Access
14 Citations
3,266 Views
7 Pages

2 April 2022

Traditionally, economic evaluations are based on clinical trials with well-defined patient populations that exclude many patient types. By contrast, studies that incorporate general patient populations end up including those in lower income categorie...

  • Article
  • Open Access
6 Citations
2,639 Views
11 Pages

Evaluation of Open Surgical and Endovascular Treatment Options for Visceral Artery Erosions after Pancreatitis and Pancreatic Surgery

  • Leon Bruder,
  • Larissa Schawe,
  • Bernhard Gebauer,
  • Jan Paul Frese,
  • Maximilian de Bucourt,
  • Katharina Beyer,
  • Johann Pratschke,
  • Andreas Greiner and
  • Safwan Omran

30 March 2022

Purpose: To report and compare the results of endovascular and open surgical treatment for erosion bleeding of visceral arteries following pancreatitis and pancreatic surgery. Materials and Methods: This retrospective study included 65 consecutive pa...

  • Review
  • Open Access
40 Citations
7,705 Views
11 Pages

Immunotherapy in Squamous Cell Cancer of the Esophagus

  • Peter Thuss-Patience and
  • Alexander Stein

30 March 2022

Treatment of esophageal carcinoma has changed dramatically following several landmark trials, which have proven the benefit of immunotherapy. The selective PD-1 (programmed cell death ligand-1)-inhibitor nivolumab has been shown to improve DFS in the...

  • Commentary
  • Open Access
4 Citations
4,828 Views
7 Pages

30 March 2022

Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant inherited cancer syndrome that has been associated with a mutation of the CDH1, and rarely the CTNNA1 gene, respectively. HDGC is characterized histologically by multifocal growth and...

  • Article
  • Open Access
15 Citations
4,345 Views
12 Pages

Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

  • Miguel A. Ortega,
  • Leonel Pekarek,
  • Oscar Fraile-Martinez,
  • Cielo Garcia-Montero,
  • Miguel A. Saez,
  • Angel Asúnsolo,
  • Miguel A. Alvarez-Mon,
  • Jorge Monserrat,
  • Lidia Ruiz-Llorente and
  • Luis G. Guijarro
  • + 4 authors

30 March 2022

Pancreatic cancer will be positioned by the year 2030 as the second cause of oncological death after lung cancer. The pathophysiology of the most common variety, which involves the adenocarcinoma of the pancreas, represents one of the main challenges...

  • Brief Report
  • Open Access
9 Citations
2,531 Views
7 Pages

The Impact of COVID-19 on Academic Cancer Clinical Trials in Canada and the Initial Response from Cancer Centers

  • Stephen Sundquist,
  • Diana Kato,
  • Rebecca Y. Xu,
  • James Schoales,
  • Saranya Kulendran and
  • Janet E. Dancey

30 March 2022

The COVID-19 pandemic resulted in temporary holds placed on new trial startups, patient recruitment and follow up visits for trials which contributed to major disruptions in cancer center trial unit operations. To assess the impact, the Canadian Canc...

  • Review
  • Open Access
7 Citations
4,343 Views
13 Pages

Optimization of the Clinical Effectiveness of Radioembolization in Hepatocellular Carcinoma with Dosimetry and Patient-Selection Criteria

  • Philippe d’Abadie,
  • Stephan Walrand,
  • Renaud Lhommel,
  • Michel Hesse,
  • Ivan Borbath and
  • François Jamar

29 March 2022

Selective internal radiation therapy (SIRT) is part of the treatment strategy for hepatocellular carcinoma (HCC). Strong clinical data demonstrated the effectiveness of this therapy in HCC with a significant improvement in patient outcomes. Recent st...

  • Article
  • Open Access
11 Citations
3,362 Views
16 Pages

Operationalizing Leadership and Clinician Buy-In to Implement Evidence-Based Tobacco Treatment Programs in Routine Oncology Care: A Mixed-Method Study of the U.S. Cancer Center Cessation Initiative

  • Sarah D. Hohl,
  • Jennifer E. Bird,
  • Claire V. T. Nguyen,
  • Heather D’Angelo,
  • Mara Minion,
  • Danielle Pauk,
  • Robert T. Adsit,
  • Michael Fiore,
  • Margaret B. Nolan and
  • Betsy Rolland

29 March 2022

Background: Delivering evidence-based tobacco dependence treatment in oncology settings improves smoking abstinence and cancer outcomes. Leadership engagement/buy-in is critical for implementation success, but few studies have defined buy-in or descr...

  • Case Report
  • Open Access
6 Citations
2,984 Views
11 Pages

Antibody-Negative Paraneoplastic Autoimmune Multiorgan Syndrome (PAMS) in a Patient with Follicular Lymphoma Accompanied by an Excess of Peripheral Blood CD8+ Lymphocytes

  • Thilo Gambichler,
  • Yi-Pei Lee,
  • Ilske Oschlies,
  • Christina H. Scheel,
  • Wolfram Klapper,
  • Nico Nowack,
  • Martin Doerler,
  • Markus Stücker,
  • Nasreddin Abolmaali and
  • Laura Susok

28 March 2022

Paraneoplastic autoimmune multiorgan syndrome (PAMS) is a life-threatening autoimmune disease associated with malignancies. Here, we present a patient initially misdiagnosed with “chronic” Stevens–Johnson syndrome. Over a year later...

  • Article
  • Open Access
7 Citations
2,797 Views
10 Pages

Concordance between Preoperative mpMRI and Pathological Stage and Its Influence on Nerve-Sparing Surgery in Patients with High-Risk Prostate Cancer

  • Clara Humke,
  • Benedikt Hoeh,
  • Felix Preisser,
  • Mike Wenzel,
  • Maria N. Welte,
  • Lena Theissen,
  • Boris Bodelle,
  • Jens Koellermann,
  • Thomas Steuber and
  • Philipp Mandel
  • + 5 authors

28 March 2022

Background: We aimed to determine the concordance between the radiologic stage (rT), using multiparametric magnetic resonance imaging (mpMRI), and pathologic stage (pT) in patients with high-risk prostate cancer and its influence on nerve-sparing sur...

  • Article
  • Open Access
3 Citations
3,519 Views
9 Pages

Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma

  • Yonghong Man,
  • Xuejun Shang,
  • Chunyu Liu,
  • Wei Zhang,
  • Qian Huang,
  • Suheng Ma,
  • Rita Shiang,
  • Feng Zhang,
  • Ling Zhang and
  • Zhibing Zhang

28 March 2022

Von Hippel-Lindau (VHL) genes are intimately involved in renal cell carcinoma (RCC), including clear cell RCC (ccRCC) pathogenesis. However, the contribution of pathogenic VHL mutations to ccRCC remains poorly understood. We report a xanthoderm with...

  • Article
  • Open Access
3 Citations
3,241 Views
12 Pages

Ectopic Recurrence of Skull Base Chordoma after Proton Therapy

  • René G. C. Santegoeds,
  • Mohammed Alahmari,
  • Alida A. Postma,
  • Norbert J. Liebsch,
  • Damien Charles Weber,
  • Hamid Mammar,
  • Daniëlle B. P. Eekers and
  • Yasin Temel

28 March 2022

Background: Chordoma are rare tumors of the axial skeleton. The treatment gold standard is surgery, followed by particle radiotherapy. Total resection is usually not achievable in skull base chordoma (SBC) and high recurrence rates are reported. Ecto...

  • Case Report
  • Open Access
6 Citations
4,171 Views
14 Pages

Characteristic of Uterine Rhabdomyosarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor

  • Saya Tamura,
  • Takuma Hayashi,
  • Tomoyuki Ichimura,
  • Nobuo Yaegashi,
  • Kaoru Abiko and
  • Ikuo Konishi

28 March 2022

Background/Aim: Patients with uterine sarcoma comprise 2–5% of all patients with uterine malignancies; however, the morbidity of uterine sarcoma is low compared with that of other gynecological cancers. For many cases, malignant uterine tumors...

  • Review
  • Open Access
18 Citations
5,731 Views
24 Pages

A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response

  • Uttam Sharma,
  • Masang Murmu,
  • Tushar Singh Barwal,
  • Hardeep Singh Tuli,
  • Manju Jain,
  • Hridayesh Prakash,
  • Tea Kaceli,
  • Aklank Jain and
  • Anupam Bishayee

26 March 2022

Despite the availability of modern techniques for the treatment of esophageal squamous cell carcinoma (ESCC), tumor recurrence and metastasis are significant challenges in clinical management. Thus, ESCC possesses a poor prognosis and low five-year o...

  • Article
  • Open Access
9 Citations
3,463 Views
14 Pages

Comprehensive Treatment of Hematological Patients with SARS-CoV-2 Infection Including Anti-SARS-CoV-2 Monoclonal Antibodies: A Single-Center Experience Case Series

  • Göran Ramin Boeckel,
  • Silke Dorothea Hölscher,
  • Christin Bürger,
  • Torid Jacob,
  • Carolin Krekeler,
  • Evgenii Shumilov,
  • Christian Reicherts,
  • Annalen Bleckmann,
  • Georg Lenz and
  • Phil-Robin Tepasse
  • + 1 author

26 March 2022

Patients with hematologic malignancies are at high risk of exacerbated condition and higher mortality from coronavirus disease 2019 (COVID-19). Bamlanivimab, casirivimab/imdevimab combination, and sotrovimab are monoclonal antibodies (mABs) that can...

  • Article
  • Open Access
2 Citations
2,858 Views
11 Pages

Impact of Surgery and Chemotherapy on Metastatic Extrauterine Leiomyosarcoma

  • Yoshinori Imura,
  • Satoshi Takenaka,
  • Hidetatsu Outani,
  • Takaaki Nakai,
  • Naohiro Yasuda,
  • Sho Nakai,
  • Toru Wakamatsu,
  • Hironari Tamiya and
  • Seiji Okada

26 March 2022

Background: Few studies have described the characteristics and prognostic factors of patients with metastatic extrauterine leiomyosarcoma (euLMS). Therefore, we retrospectively investigated the clinicopathological features, clinical outcomes, and pro...

  • Review
  • Open Access
18 Citations
5,393 Views
17 Pages

24 March 2022

The carcinogenic role of tobacco smoking is well recognized, but the detrimental effects of continued smoking after a cancer diagnosis have been underestimated. Radiotherapy is among the main treatment modalities for cancer. We reviewed the literatur...

  • Article
  • Open Access
6 Citations
3,607 Views
12 Pages

Comparison of Prognosis between Minimally Invasive and Abdominal Radical Hysterectomy for Patients with Early-Stage Cervical Cancer

  • Tomohito Tanaka,
  • Shoko Ueda,
  • Shunsuke Miyamoto,
  • Sousuke Hashida,
  • Shinichi Terada,
  • Hiromi Konishi,
  • Yuhei Kogata,
  • Kohei Taniguchi,
  • Kazumasa Komura and
  • Masahide Ohmichi

24 March 2022

Minimally invasive surgery (MIS) is performed to treat cervical cancer patients; however, a recent study showed that MIS was associated with higher recurrence and death rate compared with abdominal radical hysterectomy (ARH). In the current study, th...

of 2

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729